automatically delivering insulin to parts of the body with the help of continuous glucose
monitoring systems. For instance, in September 2017, the U.S. FDA approved first blood sugar
monitor that does not require finger pricks and uses a small sensor that can be attached to the
upper arm for continuous glucose monitoring. Moreover, in February 2018, Medtronic Plc
introduced a next generation continuous glucose monitoring system named iPro 2 Professional to
improve diabetes management in 41 economies around the world.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/market-insight/diabetes-monitoring-devices-market-1278
The key players operating the global diabetes monitoring devices market include Bayer
Healthcare AG, Medtronic, Dexcom, Sanofi, Abbott Laboratories, MediWise, Arkay, Inc., Cnoga
Medical, and Bigfoot Biomedical.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com